Loading…

Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology

Saved in:
Bibliographic Details
Published in:Internal and emergency medicine 2012-10, Vol.7 (5), p.399-401
Main Authors: Albini, Adriana, Donatelli, Francesco, Focaccetti, Chiara, D’Elios, Mario Milco, Noonan, Douglas M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c415t-b2295e0e481ddf3104845123ae63165e385bd6d000c9a95e8e78fd5dd0a2e05b3
cites cdi_FETCH-LOGICAL-c415t-b2295e0e481ddf3104845123ae63165e385bd6d000c9a95e8e78fd5dd0a2e05b3
container_end_page 401
container_issue 5
container_start_page 399
container_title Internal and emergency medicine
container_volume 7
creator Albini, Adriana
Donatelli, Francesco
Focaccetti, Chiara
D’Elios, Mario Milco
Noonan, Douglas M.
description
doi_str_mv 10.1007/s11739-012-0845-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1040944525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2764430621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-b2295e0e481ddf3104845123ae63165e385bd6d000c9a95e8e78fd5dd0a2e05b3</originalsourceid><addsrcrecordid>eNp1kMtKxDAUhoMo3h_AjQRcR0_SpBd3It5AEETXJU1OnWqnGZOUsT69kRnFjasE8v1_zvkIOeJwygGKs8B5kVUMuGBQSsXEBtnlVQGsyvJ8M91LUTKQstgheyG8AiiV82Kb7AhRSS453yXhEQfdUzuFdhxM7NxA9WBpNxiPOqClvgtv1LXUaG87F91HZ7o40WUXZzR6HeL4Oc51Q-MMvV5M51TTAZfUzHTf4_CCqWqdZW4wrncv0wHZanUf8HB97pPn66uny1t2_3Bzd3lxz4zkKrImTakQUJbc2jbjINOOXGQa84znCrNSNTa3AGAqncgSi7K1ylrQAkE12T45WfUuvHsfMcT61Y0-rRvqVAaVlEqoRPEVZbwLwWNbL3w3135KUP2tuV5prpPm-ltzLVLmeN08NnO0v4kfrwkQKyCkp2TB__36v9Yv74qJXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1040944525</pqid></control><display><type>article</type><title>Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology</title><source>Springer Nature</source><creator>Albini, Adriana ; Donatelli, Francesco ; Focaccetti, Chiara ; D’Elios, Mario Milco ; Noonan, Douglas M.</creator><creatorcontrib>Albini, Adriana ; Donatelli, Francesco ; Focaccetti, Chiara ; D’Elios, Mario Milco ; Noonan, Douglas M.</creatorcontrib><identifier>ISSN: 1828-0447</identifier><identifier>EISSN: 1970-9366</identifier><identifier>DOI: 10.1007/s11739-012-0845-2</identifier><identifier>PMID: 22941411</identifier><language>eng</language><publisher>Milan: Springer Milan</publisher><subject>Antibodies, Monoclonal, Humanized - adverse effects ; Antineoplastic Combined Chemotherapy Protocols - adverse effects ; Breast Neoplasms - drug therapy ; Female ; Heart Diseases - chemically induced ; Humans ; Im - Commentary ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Renal Insufficiency - complications ; Trastuzumab</subject><ispartof>Internal and emergency medicine, 2012-10, Vol.7 (5), p.399-401</ispartof><rights>SIMI 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-b2295e0e481ddf3104845123ae63165e385bd6d000c9a95e8e78fd5dd0a2e05b3</citedby><cites>FETCH-LOGICAL-c415t-b2295e0e481ddf3104845123ae63165e385bd6d000c9a95e8e78fd5dd0a2e05b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22941411$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Albini, Adriana</creatorcontrib><creatorcontrib>Donatelli, Francesco</creatorcontrib><creatorcontrib>Focaccetti, Chiara</creatorcontrib><creatorcontrib>D’Elios, Mario Milco</creatorcontrib><creatorcontrib>Noonan, Douglas M.</creatorcontrib><title>Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology</title><title>Internal and emergency medicine</title><addtitle>Intern Emerg Med</addtitle><addtitle>Intern Emerg Med</addtitle><subject>Antibodies, Monoclonal, Humanized - adverse effects</subject><subject>Antineoplastic Combined Chemotherapy Protocols - adverse effects</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Female</subject><subject>Heart Diseases - chemically induced</subject><subject>Humans</subject><subject>Im - Commentary</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Renal Insufficiency - complications</subject><subject>Trastuzumab</subject><issn>1828-0447</issn><issn>1970-9366</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKxDAUhoMo3h_AjQRcR0_SpBd3It5AEETXJU1OnWqnGZOUsT69kRnFjasE8v1_zvkIOeJwygGKs8B5kVUMuGBQSsXEBtnlVQGsyvJ8M91LUTKQstgheyG8AiiV82Kb7AhRSS453yXhEQfdUzuFdhxM7NxA9WBpNxiPOqClvgtv1LXUaG87F91HZ7o40WUXZzR6HeL4Oc51Q-MMvV5M51TTAZfUzHTf4_CCqWqdZW4wrncv0wHZanUf8HB97pPn66uny1t2_3Bzd3lxz4zkKrImTakQUJbc2jbjINOOXGQa84znCrNSNTa3AGAqncgSi7K1ylrQAkE12T45WfUuvHsfMcT61Y0-rRvqVAaVlEqoRPEVZbwLwWNbL3w3135KUP2tuV5prpPm-ltzLVLmeN08NnO0v4kfrwkQKyCkp2TB__36v9Yv74qJXg</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Albini, Adriana</creator><creator>Donatelli, Francesco</creator><creator>Focaccetti, Chiara</creator><creator>D’Elios, Mario Milco</creator><creator>Noonan, Douglas M.</creator><general>Springer Milan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20121001</creationdate><title>Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology</title><author>Albini, Adriana ; Donatelli, Francesco ; Focaccetti, Chiara ; D’Elios, Mario Milco ; Noonan, Douglas M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-b2295e0e481ddf3104845123ae63165e385bd6d000c9a95e8e78fd5dd0a2e05b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antibodies, Monoclonal, Humanized - adverse effects</topic><topic>Antineoplastic Combined Chemotherapy Protocols - adverse effects</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Female</topic><topic>Heart Diseases - chemically induced</topic><topic>Humans</topic><topic>Im - Commentary</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Renal Insufficiency - complications</topic><topic>Trastuzumab</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Albini, Adriana</creatorcontrib><creatorcontrib>Donatelli, Francesco</creatorcontrib><creatorcontrib>Focaccetti, Chiara</creatorcontrib><creatorcontrib>D’Elios, Mario Milco</creatorcontrib><creatorcontrib>Noonan, Douglas M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Family Health Database (Proquest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Internal and emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Albini, Adriana</au><au>Donatelli, Francesco</au><au>Focaccetti, Chiara</au><au>D’Elios, Mario Milco</au><au>Noonan, Douglas M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology</atitle><jtitle>Internal and emergency medicine</jtitle><stitle>Intern Emerg Med</stitle><addtitle>Intern Emerg Med</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>7</volume><issue>5</issue><spage>399</spage><epage>401</epage><pages>399-401</pages><issn>1828-0447</issn><eissn>1970-9366</eissn><cop>Milan</cop><pub>Springer Milan</pub><pmid>22941411</pmid><doi>10.1007/s11739-012-0845-2</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1828-0447
ispartof Internal and emergency medicine, 2012-10, Vol.7 (5), p.399-401
issn 1828-0447
1970-9366
language eng
recordid cdi_proquest_journals_1040944525
source Springer Nature
subjects Antibodies, Monoclonal, Humanized - adverse effects
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Breast Neoplasms - drug therapy
Female
Heart Diseases - chemically induced
Humans
Im - Commentary
Internal Medicine
Medicine
Medicine & Public Health
Renal Insufficiency - complications
Trastuzumab
title Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T04%3A11%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Renal%20dysfunction%20and%20increased%20risk%20of%20cardiotoxicity%20with%20trastuzumab%20therapy:%20a%20new%20challenge%20in%20cardio-oncology&rft.jtitle=Internal%20and%20emergency%20medicine&rft.au=Albini,%20Adriana&rft.date=2012-10-01&rft.volume=7&rft.issue=5&rft.spage=399&rft.epage=401&rft.pages=399-401&rft.issn=1828-0447&rft.eissn=1970-9366&rft_id=info:doi/10.1007/s11739-012-0845-2&rft_dat=%3Cproquest_cross%3E2764430621%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-b2295e0e481ddf3104845123ae63165e385bd6d000c9a95e8e78fd5dd0a2e05b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1040944525&rft_id=info:pmid/22941411&rfr_iscdi=true